Sonia I Chaves, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27 Calle Barbosa, Isabela, PR 00662 Phone: 787-872-4545 Fax: 787-872-4580 |
Ashley Quinones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1152 Calle Inglaterra, Isabela, PR 00662 Phone: 939-274-8469 |
Mrs. Sonia Mabel Abreu, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ave Juan Hernandez Ortiz #1, Isabela, PR 00662 Phone: 787-872-2590 Fax: 787-872-1733 |
Miss Damaris Nilda Abreu, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ave Juan Hernandez Ortiz #1, Isabela, PR 00662 Phone: 787-648-6531 Fax: 787-872-1733 |
Fransheska M Feliciano Cruz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Solar 6 Bo Galateo Bajo, Carr. 466 #587, Isabela, PR 00662 Phone: 787-830-3335 |
News Archive
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
Injuries to the spinal cord can cause paralysis and other permanent disabilities because severed nerve fibers do not regrow. Now, scientists of the German Center for Neurodegenerative Diseases have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections.
Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal fourth quarter and full year ended December 31, 2009.
Changes to the 2007 immunization schedules for children and adolescents in the U.S. - issued by the American Academy of Pediatrics on Tuesday and approved by CDC and the American Academy of Family Physicians - include recommending that girls ages 11 and 12 receive Merck's human papillomavirus vaccine Gardasil, Reuters Health reports .
› Verified 4 days ago